NASDAQ:VTL - Vital Therapies Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$6.07 -0.18 (-2.88 %)
(As of 05/23/2018 01:10 AM ET)
Previous Close$6.25
Today's Range$6.05 - $6.50
52-Week Range$2.25 - $7.30
Volume225,900 shs
Average Volume196,555 shs
Market Capitalization$271.16 million
P/E Ratio-4.63
Dividend YieldN/A
Beta4.29

About Vital Therapies (NASDAQ:VTL)

Vital Therapies logoVital Therapies, Inc., a biotherapeutic company, focuses on developing and commercializing a cell-based therapy for the treatment of acute forms of liver failure in the United States. Its product candidate is the ELAD system, an extracorporeal human allogeneic cellular liver therapy that is in Phase III clinical trials helps in enhancing the rates of survival in patients with acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, Inc. in June 2003. Vital Therapies, Inc. was founded in 2003 and is headquartered in San Diego, California.

Receive VTL News and Ratings via Email

Sign-up to receive the latest news and ratings for VTL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VTL
CUSIPN/A
Phone858-673-6840

Debt

Debt-to-Equity RatioN/A
Current Ratio4.64
Quick Ratio4.64

Price-To-Earnings

Trailing P/E Ratio-4.63
Forward P/E Ratio-4.93
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$1.19 per share
Price / Book5.10

Profitability

EPS (Most Recent Fiscal Year)($1.31)
Net Income$-52,070,000.00
Net MarginsN/A
Return on Equity-96.73%
Return on Assets-83.38%

Miscellaneous

Employees97
Outstanding Shares42,370,000

Vital Therapies (NASDAQ:VTL) Frequently Asked Questions

What is Vital Therapies' stock symbol?

Vital Therapies trades on the NASDAQ under the ticker symbol "VTL."

How were Vital Therapies' earnings last quarter?

Vital Therapies Inc (NASDAQ:VTL) posted its quarterly earnings results on Tuesday, May, 8th. The company reported ($0.34) earnings per share for the quarter, hitting the Zacks' consensus estimate of ($0.34). View Vital Therapies' Earnings History.

When is Vital Therapies' next earnings date?

Vital Therapies is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Vital Therapies.

Who are some of Vital Therapies' key competitors?

Who are Vital Therapies' key executives?

Vital Therapies' management team includes the folowing people:
  • Dr. Duane Nash M.D., J.D., M.B.A, Pres (Age 47)
  • Mr. Robert A. Ashley M.A., Chief Technical Officer and Exec. VP (Age 60)
  • Mr. Russell J. Cox, CEO & Director (Age 55)
  • Mr. Michael V. Swanson M.B.A, Chief Financial Officer, Exec. VP and Treasurer (Age 63)
  • Mr. Aron P. Stern M.B.A., Chief Admin. Officer (Age 64)

Has Vital Therapies been receiving favorable news coverage?

News headlines about VTL stock have trended somewhat positive recently, Accern reports. Accern rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vital Therapies earned a media sentiment score of 0.18 on Accern's scale. They also gave press coverage about the company an impact score of 45.53 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Vital Therapies' major shareholders?

Vital Therapies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (7.05%), Artal Group S.A. (2.36%), BlackRock Inc. (2.25%), Millennium Management LLC (0.98%), Chicago Capital LLC (0.23%) and Northern Trust Corp (0.20%). Company insiders that own Vital Therapies stock include Duane Nash, Faheem Hasnain, Jean Jacques Bienaime, John Michael Dunn, Muneer A Satter, Robert A Ashley and Terence E Winters. View Institutional Ownership Trends for Vital Therapies.

Which major investors are selling Vital Therapies stock?

VTL stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., New York State Common Retirement Fund and Barclays PLC. View Insider Buying and Selling for Vital Therapies.

Which major investors are buying Vital Therapies stock?

VTL stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Artal Group S.A., Chicago Capital LLC, Tibra Equities Europe Ltd, Victory Capital Management Inc., Element Capital Management LLC, Annex Advisory Services LLC and Dowling & Yahnke LLC. Company insiders that have bought Vital Therapies stock in the last two years include Duane Nash, Faheem Hasnain, Jean Jacques Bienaime, John Michael Dunn, Muneer A Satter, Robert A Ashley and Terence E Winters. View Insider Buying and Selling for Vital Therapies.

How do I buy shares of Vital Therapies?

Shares of VTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vital Therapies' stock price today?

One share of VTL stock can currently be purchased for approximately $6.07.

How big of a company is Vital Therapies?

Vital Therapies has a market capitalization of $271.16 million. The company earns $-52,070,000.00 in net income (profit) each year or ($1.31) on an earnings per share basis. Vital Therapies employs 97 workers across the globe.

How can I contact Vital Therapies?

Vital Therapies' mailing address is 15010 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The company can be reached via phone at 858-673-6840 or via email at [email protected]


MarketBeat Community Rating for Vital Therapies (VTL)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  168 (Vote Outperform)
Underperform Votes:  150 (Vote Underperform)
Total Votes:  318
MarketBeat's community ratings are surveys of what our community members think about Vital Therapies and other stocks. Vote "Outperform" if you believe VTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VTL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Vital Therapies (NASDAQ:VTL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Vital Therapies in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.502.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/A$6.00$6.00$8.00
Price Target Upside: N/A25.00% upside25.00% upside207.69% upside

Vital Therapies (NASDAQ:VTL) Consensus Price Target History

Price Target History for Vital Therapies (NASDAQ:VTL)

Vital Therapies (NASDAQ:VTL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/5/2017Raymond JamesReiterated RatingBuyHighView Rating Details
3/10/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
1/2/2017Canaccord GenuitySet Price TargetBuy$10.00N/AView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Vital Therapies (NASDAQ:VTL) Earnings History and Estimates Chart

Earnings by Quarter for Vital Therapies (NASDAQ:VTL)

Vital Therapies (NASDAQ:VTL) Earnings Estimates

2018 EPS Consensus Estimate: ($1.35)
2019 EPS Consensus Estimate: ($1.42)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.36)($0.36)($0.36)
Q2 20181($0.36)($0.36)($0.36)
Q3 20181($0.33)($0.33)($0.33)
Q4 20181($0.30)($0.30)($0.30)
Q1 20191($0.30)($0.30)($0.30)
Q2 20191($0.29)($0.29)($0.29)
Q3 20191($0.40)($0.40)($0.40)
Q4 20191($0.43)($0.43)($0.43)

Vital Therapies (NASDAQ VTL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018($0.31)N/AView Earnings Details
5/8/2018Q1 2018($0.34)($0.34)ViewN/AView Earnings Details
3/13/2018Q4 2017($0.31)($0.35)ViewListenView Earnings Details
10/25/2017Q3 2017($0.32)($0.30)ViewN/AView Earnings Details
8/3/2017Q2 2017($0.30)($0.29)ViewListenView Earnings Details
5/9/2017Q1 2017($0.37)($0.39)ViewListenView Earnings Details
3/7/2017Q4 2016($0.36)($0.37)ViewListenView Earnings Details
11/3/2016Q316($0.32)($0.32)ViewN/AView Earnings Details
8/2/2016Q216($0.33)($0.30)ViewN/AView Earnings Details
5/9/2016Q1($0.28)($0.31)ViewN/AView Earnings Details
3/8/2016Q415($0.42)($0.34)ViewN/AView Earnings Details
11/5/2015Q315($0.58)($0.51)ViewListenView Earnings Details
7/30/2015Q215($0.62)($0.63)ViewListenView Earnings Details
5/12/2015Q1($0.62)($0.62)ViewListenView Earnings Details
3/19/2015Q414($0.59)($0.59)ViewListenView Earnings Details
11/13/2014Q314($0.63)($0.59)ViewN/AView Earnings Details
8/6/2014Q214($0.04)($0.91)ViewN/AView Earnings Details
6/3/2014($0.54)($24.49)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Vital Therapies (NASDAQ:VTL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Vital Therapies (NASDAQ VTL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 33.90%
Institutional Ownership Percentage: 28.20%
Insider Trading History for Vital Therapies (NASDAQ:VTL)
Institutional Ownership by Quarter for Vital Therapies (NASDAQ:VTL)

Vital Therapies (NASDAQ VTL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2017Muneer A SatterDirectorBuy100,000$5.48$548,000.00View SEC Filing  
12/11/2017Muneer A SatterDirectorBuy150,000$4.89$733,500.00View SEC Filing  
12/7/2017Muneer A SatterDirectorBuy50,000$4.77$238,500.00View SEC Filing  
9/14/2017Muneer A SatterDirectorBuy130,000$4.01$521,300.00View SEC Filing  
9/13/2017Jean Jacques BienaimeDirectorBuy10,000$4.00$40,000.0065,119View SEC Filing  
9/8/2017Muneer A SatterDirectorBuy50,000$3.53$176,500.00View SEC Filing  
6/14/2017John Michael DunnGeneral CounselBuy2,500$3.09$7,725.009,485View SEC Filing  
6/14/2017Muneer A SatterDirectorBuy20,000$3.07$61,400.00View SEC Filing  
6/14/2017Terence E WintersChairmanBuy10,000$3.10$31,000.00194,966View SEC Filing  
6/13/2017Muneer A SatterDirectorBuy10,000$3.03$30,300.00View SEC Filing  
6/12/2017Muneer A SatterDirectorBuy30,000$3.11$93,300.00View SEC Filing  
6/9/2017Robert A AshleyInsiderBuy2,000$3.18$6,360.002,000View SEC Filing  
6/8/2017Duane NashPresidentBuy3,900$3.12$12,168.008,224View SEC Filing  
6/7/2017Muneer A SatterDirectorBuy20,000$3.20$64,000.00View SEC Filing  
6/6/2017Muneer A SatterDirectorBuy10,000$3.19$31,900.00View SEC Filing  
3/27/2017Muneer A SatterDirectorBuy3,750,000$4.00$15,000,000.00View SEC Filing  
8/12/2016Faheem HasnainDirectorBuy118,243$5.92$699,998.56122,743View SEC Filing  
10/28/2015Muneer A SatterDirectorBuy400,000$5.50$2,200,000.00View SEC Filing  
10/26/2015Cheryl CohenDirectorBuy3,500$7.17$25,095.00View SEC Filing  
10/26/2015John Michael DunnGeneral CounselBuy9,385$6.81$63,911.859,385View SEC Filing  
9/10/2015Jean Jacques BienaimeDirectorBuy14,000$3.08$43,120.0039,119View SEC Filing  
10/10/2014Terence E WintersCEOBuy1,360$14.86$20,209.60View SEC Filing  
10/8/2014Duane NashInsiderBuy100$17.50$1,750.00View SEC Filing  
10/8/2014Lowell SearsDirectorBuy1,429$17.50$25,007.50View SEC Filing  
6/3/2014Muneer A SatterDirectorBuy14,500$13.16$190,820.00View SEC Filing  
4/23/2014Muneer A SatterDirectorBuy360,966$12.00$4,331,592.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Vital Therapies (NASDAQ VTL) News Headlines

Source:
DateHeadline
Vital Therapies (VTL) Upgraded to Hold at BidaskClubVital Therapies (VTL) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - May 19 at 10:56 AM
Vital Therapies (VTL) Expected to Announce Earnings of -$0.33 Per ShareVital Therapies (VTL) Expected to Announce Earnings of -$0.33 Per Share
www.americanbankingnews.com - May 15 at 5:18 AM
Vital Therapies (VTL) Raised to Hold at Zacks Investment ResearchVital Therapies (VTL) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - May 12 at 12:13 PM
Vital Therapies to Host Analyst R&D Day on May 24, 2018Vital Therapies to Host Analyst R&D Day on May 24, 2018
finance.yahoo.com - May 11 at 8:30 AM
Q2 2018 Earnings Estimate for Vital Therapies (VTL) Issued By William BlairQ2 2018 Earnings Estimate for Vital Therapies (VTL) Issued By William Blair
www.americanbankingnews.com - May 11 at 8:27 AM
Edited Transcript of VTL earnings conference call or presentation 8-May-18 8:30pm GMTEdited Transcript of VTL earnings conference call or presentation 8-May-18 8:30pm GMT
finance.yahoo.com - May 10 at 8:26 AM
Vital Therapies (VTL) Posts Quarterly  Earnings Results, Hits ExpectationsVital Therapies (VTL) Posts Quarterly Earnings Results, Hits Expectations
www.americanbankingnews.com - May 9 at 1:59 PM
Vital Therapies (VTL) CEO Russell Cox on Q1 2018 Results - Earnings Call TranscriptVital Therapies' (VTL) CEO Russell Cox on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 8:20 AM
Vital Therapies Announces First Quarter 2018 Financial ResultsVital Therapies Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 8 at 5:38 PM
Vital Therapies: 1Q Earnings SnapshotVital Therapies: 1Q Earnings Snapshot
finance.yahoo.com - May 8 at 5:38 PM
What Does Vistal Gdynia SA.’s (WSE:VTL) Ownership Structure Look Like?What Does Vistal Gdynia SA.’s (WSE:VTL) Ownership Structure Look Like?
finance.yahoo.com - May 7 at 5:37 PM
Vital Therapies (VTL) Upgraded by ValuEngine to HoldVital Therapies (VTL) Upgraded by ValuEngine to Hold
www.americanbankingnews.com - May 2 at 2:02 PM
Head-To-Head Review: Vital Therapies (VTL) vs. Jazz Pharmaceuticals (JAZZ)Head-To-Head Review: Vital Therapies (VTL) vs. Jazz Pharmaceuticals (JAZZ)
www.americanbankingnews.com - April 30 at 5:18 PM
Vital Therapies (VTL) Scheduled to Post Quarterly Earnings on MondayVital Therapies (VTL) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 30 at 9:41 AM
Zacks: Brokerages Expect Vital Therapies (VTL) Will Announce Earnings of -$0.34 Per ShareZacks: Brokerages Expect Vital Therapies (VTL) Will Announce Earnings of -$0.34 Per Share
www.americanbankingnews.com - April 27 at 3:14 PM
Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with WebcastVital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast
finance.yahoo.com - April 26 at 5:16 PM
Are Vistal Gdynia SA.’s (WSE:VTL) Interest Costs Too High?Are Vistal Gdynia SA.’s (WSE:VTL) Interest Costs Too High?
finance.yahoo.com - April 25 at 5:28 PM
Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Vital Therapies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - April 25 at 5:28 PM
Will Vital Therapies Inc’s (NASDAQ:VTL) Earnings Grow In The Next Couple Of Years?Will Vital Therapies Inc’s (NASDAQ:VTL) Earnings Grow In The Next Couple Of Years?
finance.yahoo.com - April 12 at 8:39 AM
 Analysts Anticipate Vital Therapies (VTL) Will Post Earnings of -$0.34 Per Share Analysts Anticipate Vital Therapies (VTL) Will Post Earnings of -$0.34 Per Share
www.americanbankingnews.com - April 10 at 5:14 PM
Vital Therapies (VTL) Stock Rating Lowered by BidaskClubVital Therapies (VTL) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 10 at 8:27 AM
Vital Therapies (VTL) Upgraded by BidaskClub to BuyVital Therapies (VTL) Upgraded by BidaskClub to Buy
www.americanbankingnews.com - April 4 at 12:55 PM
Vital Therapies (VTL) Lowered to "Hold" at BidaskClubVital Therapies (VTL) Lowered to "Hold" at BidaskClub
www.americanbankingnews.com - March 31 at 11:34 PM
ValuEngine Upgrades Vital Therapies (VTL) to "Sell"ValuEngine Upgrades Vital Therapies (VTL) to "Sell"
www.americanbankingnews.com - March 28 at 11:55 AM
BRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 SubjectsBRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 Subjects
www.reuters.com - March 22 at 5:35 PM
Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 SubjectsVital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects
finance.yahoo.com - March 22 at 8:28 AM
Options Traders Expect Huge Moves in Vital Therapies (VTL) StockOptions Traders Expect Huge Moves in Vital Therapies (VTL) Stock
www.zacks.com - March 20 at 8:29 AM
Vital Therapies (VTL) Lowered to Sell at Zacks Investment ResearchVital Therapies (VTL) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 17 at 10:31 AM
Edited Transcript of VTL earnings conference call or presentation 13-Mar-18 8:30pm GMTEdited Transcript of VTL earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 16 at 6:28 PM
Vital Therapies Inc to Post Q1 2018 Earnings of ($0.36) Per Share, William Blair Forecasts (VTL)Vital Therapies Inc to Post Q1 2018 Earnings of ($0.36) Per Share, William Blair Forecasts (VTL)
www.americanbankingnews.com - March 16 at 7:44 AM
Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial ResultsVital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 14 at 8:34 AM
Vital Therapies (VTL) Announces Quarterly  Earnings Results, Misses Expectations By $0.04 EPSVital Therapies (VTL) Announces Quarterly Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - March 13 at 9:14 PM
Vital Therapies, Inc. to Host Earnings CallVital Therapies, Inc. to Host Earnings Call
www.baystreet.ca - March 13 at 7:15 PM
When Will Vital Therapies Inc (NASDAQ:VTL) Breakeven?When Will Vital Therapies Inc (NASDAQ:VTL) Breakeven?
finance.yahoo.com - March 13 at 8:27 AM
Vital Therapies (VTL) to Release Earnings on TuesdayVital Therapies (VTL) to Release Earnings on Tuesday
www.americanbankingnews.com - March 6 at 3:52 AM
Vital Therapies Announces Upcoming Fourth Quarter and Full Year Financial Results Conference Call with Webcast and Participation in Upcoming ConferenceVital Therapies Announces Upcoming Fourth Quarter and Full Year Financial Results Conference Call with Webcast and Participation in Upcoming Conference
finance.yahoo.com - February 27 at 8:20 AM
Vital Therapies (VTL) to Release Quarterly Earnings on MondayVital Therapies (VTL) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - February 26 at 3:56 AM
Vital Therapies Inc (VTL) Expected to Announce Earnings of -$0.30 Per ShareVital Therapies Inc (VTL) Expected to Announce Earnings of -$0.30 Per Share
www.americanbankingnews.com - February 18 at 7:20 PM
-$0.30 Earnings Per Share Expected for Vital Therapies Inc (VTL) This Quarter-$0.30 Earnings Per Share Expected for Vital Therapies Inc (VTL) This Quarter
www.americanbankingnews.com - February 1 at 9:12 PM
Vital Therapies (VTL) Stock Rating Upgraded by BidaskClubVital Therapies (VTL) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - February 1 at 12:30 AM
Contrasting Halozyme Therapeutics (HALO) and Vital Therapies (VTL)Contrasting Halozyme Therapeutics (HALO) and Vital Therapies (VTL)
www.americanbankingnews.com - January 21 at 1:16 AM
Vital Therapies Inc (VTL) Expected to Post Earnings of -$0.30 Per ShareVital Therapies Inc (VTL) Expected to Post Earnings of -$0.30 Per Share
www.americanbankingnews.com - January 15 at 9:14 PM
Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - January 5 at 10:40 AM
 Brokerages Expect Vital Therapies Inc (VTL) to Post -$0.30 EPS Brokerages Expect Vital Therapies Inc (VTL) to Post -$0.30 EPS
www.americanbankingnews.com - December 30 at 1:24 AM
Vital Therapies, Inc. (VTL) Receives Average Rating of "Hold" from BrokeragesVital Therapies, Inc. (VTL) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - December 19 at 3:36 AM
Insider Buying: Vital Therapies, Inc. (VTL) Director Buys 100,000 Shares of StockInsider Buying: Vital Therapies, Inc. (VTL) Director Buys 100,000 Shares of Stock
www.americanbankingnews.com - December 14 at 8:52 PM
 Analysts Expect Vital Therapies, Inc. (VTL) to Announce -$0.30 EPS Analysts Expect Vital Therapies, Inc. (VTL) to Announce -$0.30 EPS
www.americanbankingnews.com - December 12 at 11:14 PM
Insider Buying: Vital Therapies, Inc. (VTL) Director Purchases 50,000 Shares of StockInsider Buying: Vital Therapies, Inc. (VTL) Director Purchases 50,000 Shares of Stock
www.americanbankingnews.com - December 11 at 8:50 PM
Vital Therapies, Inc. (VTL) Director Muneer A. Satter Buys 150,000 SharesVital Therapies, Inc. (VTL) Director Muneer A. Satter Buys 150,000 Shares
www.americanbankingnews.com - December 11 at 8:26 PM
Vital Therapies Added to NASDAQ Biotechnology IndexVital Therapies Added to NASDAQ Biotechnology Index
finance.yahoo.com - December 11 at 11:10 AM

SEC Filings

Vital Therapies (NASDAQ:VTL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Vital Therapies (NASDAQ:VTL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Vital Therapies (NASDAQ VTL) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.